bimekizumab
3 NDCs across 1 manufacturer|0 Generic,3 Brand
Bimekizumab is available as 3 NDCs from 1 manufacturer (0 generic, 3 brand), with NADAC prices from $8023.84 to $8112.59 per unit — a 1% spread. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
3
0G / 3B
Manufacturers
1
competing in market
Price Spread
$8023.84 – $8112.59
Up to 1% savings
7d Activity
avg -0.1% WoW · of 3 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Frequently Asked Questions
How many Bimekizumab products are on the market?
The Bimekizumab drug market contains 3 NDCs from 1 manufacturer — 0 generic and 3 brand products.
What is the price range for Bimekizumab?
NADAC reference prices for Bimekizumab range from $8023.8367 to $8112.5853 per unit, a 1% spread between the cheapest and most expensive product.
Which manufacturers make Bimekizumab?
1 manufacturer lists Bimekizumab in NADAC. Ranked by number of NDCs, the largest are UCB, Inc. (3).
How has the price of Bimekizumab changed recently?
Over the past 7 days, 0 Bimekizumab NDCs rose and 1 fell, with a market-wide average change of -0.1%.
Manufacturer Breakdown
1 manufacturer producing bimekizumab
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
BIMZELX 160 MG/ML AUTOINJECTOR | $8112.5853 per ML | — |
BIMZELX 160 MG/ML AUTOINJECTOR | $8046.4268 per ML | — |
BIMZELX 320 MG/2 ML AUTOINJECT | $8023.8367 per ML | -0.10% |